EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY 4.0

Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study

Makoto Okabe, Shuji Yamamoto, Masahiro Shiokawa, Tadakazu Hisamatsu, Hajime Yamazaki, Risa Nakanishi, Kensuke Hamada, Hiroki Kitamoto, Takeshi Kuwada, Norimitsu Uza, Aki Sakatani, Toshimitsu Fujii und 30 weitere

Journal of Gastroenterology · 2025-01 · 60 (1) · 86-95

DOI: 10.1007/s00535-024-02176-x ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, online erschienen am 28.11.2024. Verfasst von Makoto Okabe und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Jap…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Biomarkers, Sensitivity and Specificity, Integrins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agency for Medical Research and Development, Medical and Biological Laboratories Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A serum biomarker for diagnosing ulcerative colitis (UC) remains to be established. Although we recently reported an anti-integrin αvβ6 antibody (V6 Ab) for diagnosing UC with high sensitivity and specificity, no large-scale validation study exists. This study aimed to validate the diagnostic value of V6 Ab for UC using a nationwide multicenter cohort study.

Methods

We measured V6 Ab titers in patients definitively diagnosed with UC, Crohn’s disease (CD), or other gastrointestinal disorders (OGDs). The primary outcome was the diagnostic value of V6 Ab. Secondary outcomes were factors associated with false-negative results in patients with UC and false-positive results in patients without UC and the heterogeneity of the diagnostic value of V6 Ab among the participating facilities.

Results

We enrolled 1241, 796, and 206 patients with UC, CD, and OGD, respectively, from 28 Japanese high-volume referral centers. The diagnostic sensitivity of V6 Ab for UC was 87.7%, and its specificities for CD and OGDs were 82.0% and 87.4%, respectively. Multivariable logistic regression analysis showed that false-negative results were associated with older age at the time of sample collection, current smokers, lower partial Mayo score, and not receiving advanced therapies in patients with UC, and false-positive results were associated with colonic CD in patients with CD. No factor was associated with false-positive results in patients with OGDs. There were no significant differences in the diagnostic value of V6 Ab among the centers.

Conclusions

The diagnostic value of V6 Ab for UC was validated in the large-scale nationwide multicenter study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeBiomarkersSensitivity and SpecificityIntegrinsAntigens, NeoplasmHumansFemaleMaleMiddle AgedAdultAgedCrohn DiseaseJapanYoung AdultCohort StudiesFalse Negative ReactionsFalse Positive Reactions

Stichwörter der Autor:innen

Anti-integrin αvβ6 antibodyColonic Crohn’s diseaseDiagnostic biomarkerUlcerative colitis

Substanzen

BiomarkersIntegrinsAntigens, Neoplasmintegrin alphavbeta6

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. shuyama@kuhp.kyoto-u.ac.jp.
  • Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. machan@kuhp.kyoto-u.ac.jp.
  • Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Mitaka-shi, Tokyo, 181-8611, Japan. thisamatsu@ks.kyorin-u.ac.jp.
  • Section of Clinical Epidemiology, Department of Community Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
  • Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, 078-8510, Japan.

Förderung

  • Agency for Medical Research and Development
  • Medical and Biological Laboratories Co., Ltd.

Zitieren

APA

Okabe, M., Yamamoto, S., Shiokawa, M., Hisamatsu, T., Yamazaki, H., Nakanishi, R., Hamada, K., Kitamoto, H., Kuwada, T., Uza, N., Sakatani, A., Fujii, T., Ohno, M., Matsuura, M., Shibuya, T., Ohmiya, N., Ooi, M., Hoshi, N., Moriya, K., …, & Seno, H. (2025). Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study. Journal of Gastroenterology, 60(1), 86-95. https://doi.org/10.1007/s00535-024-02176-x

Vancouver

Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, et al. Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study. Journal of Gastroenterology. 2025;60(1):86-95. doi:10.1007/s00535-024-02176-x

BibTeX
@article{Okabe2025,
  author = {Okabe, Makoto and Yamamoto, Shuji and Shiokawa, Masahiro and Hisamatsu, Tadakazu and Yamazaki, Hajime and Nakanishi, Risa and Hamada, Kensuke and Kitamoto, Hiroki and Kuwada, Takeshi and Uza, Norimitsu and Sakatani, Aki and Fujii, Toshimitsu and Ohno, Masashi and Matsuura, Minoru and Shibuya, Tomoyoshi and Ohmiya, Naoki and Ooi, Makoto and Hoshi, Namiko and Moriya, Kei and Tsuchiya, Kiichiro and Yamaguchi, Yoshiharu and Kunisaki, Reiko and Takahara, Masahiro and Takagi, Tomohisa and Takehara, Tetsuo and Hirai, Fumihito and Kakimoto, Kazuki and Esaki, Motohiro and Nakase, Hiroshi and Kinjo, Fukunori and Torisu, Takehiro and Kanmura, Shuji and Narimatsu, Kazuyuki and Matsuoka, Katsuyoshi and Hiraga, Hiroto and Yokoyama, Kaoru and Honzawa, Yusuke and Naganuma, Makoto and Saruta, Masayuki and Kodama, Yuzo and Chiba, Tsutomu and Seno, Hiroshi},
  title = {Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study},
  journal = {Journal of Gastroenterology},
  year = {2025},
  volume = {60},
  number = {1},
  pages = {86--95},
  doi = {10.1007/s00535-024-02176-x}
}
Kostenlos starten →